Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 240

    1.

    Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial.

    Nass R, Pezzoli SS, Oliveri MC, Patrie JT, Harrell FE Jr, Clasey JL, Heymsfield SB, Bach MA, Vance ML, Thorner MO.

    Ann Intern Med. 2008 Nov 4;149(9):601-11.PMID: 18981485 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Two-month treatment of obese subjects with the oral growth hormone (GH) secretagogue MK-677 increases GH secretion, fat-free mass, and energy expenditure.

    Svensson J, Lönn L, Jansson JO, Murphy G, Wyss D, Krupa D, Cerchio K, Polvino W, Gertz B, Boseaus I, Sjöström L, Bengtsson BA.

    J Clin Endocrinol Metab. 1998 Feb;83(2):362-9.PMID: 9467542 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Summaries for patients. Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults.

    [No authors listed]

    Ann Intern Med. 2008 Nov 4;149(9):I-36. No abstract available. PMID: 18981483 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    The effect of six months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women.

    Morales AJ, Haubrich RH, Hwang JY, Asakura H, Yen SS.

    Clin Endocrinol (Oxf). 1998 Oct;49(4):421-32.PMID: 9876338 [PubMed - indexed for MEDLINE]Related articles

    5.

    Effects of growth hormone administration on inflammatory and other cardiovascular risk markers in men with growth hormone deficiency. A randomized, controlled clinical trial.

    Sesmilo G, Biller BM, Llevadot J, Hayden D, Hanson G, Rifai N, Klibanski A.

    Ann Intern Med. 2000 Jul 18;133(2):111-22.PMID: 10896637 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Growth hormone and sex steroid administration in healthy aged women and men: a randomized controlled trial.

    Blackman MR, Sorkin JD, Münzer T, Bellantoni MF, Busby-Whitehead J, Stevens TE, Jayme J, O'Connor KG, Christmas C, Tobin JD, Stewart KJ, Cottrell E, St Clair C, Pabst KM, Harman SM.

    JAMA. 2002 Nov 13;288(18):2282-92.PMID: 12425705 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Stimulation of the growth hormone (GH)-insulin-like growth factor I axis by daily oral administration of a GH secretogogue (MK-677) in healthy elderly subjects.

    Chapman IM, Bach MA, Van Cauter E, Farmer M, Krupa D, Taylor AM, Schilling LM, Cole KY, Skiles EH, Pezzoli SS, Hartman ML, Veldhuis JD, Gormley GJ, Thorner MO.

    J Clin Endocrinol Metab. 1996 Dec;81(12):4249-57.PMID: 8954023 [PubMed - indexed for MEDLINE]Related articles

    8.

    Oral administration of growth hormone (GH) releasing peptide-mimetic MK-677 stimulates the GH/insulin-like growth factor-I axis in selected GH-deficient adults.

    Chapman IM, Pescovitz OH, Murphy G, Treep T, Cerchio KA, Krupa D, Gertz B, Polvino WJ, Skiles EH, Pezzoli SS, Thorner MO.

    J Clin Endocrinol Metab. 1997 Oct;82(10):3455-63.PMID: 9329386 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Low-dose physiological growth hormone in patients with HIV and abdominal fat accumulation: a randomized controlled trial.

    Lo J, You SM, Canavan B, Liebau J, Beltrani G, Koutkia P, Hemphill L, Lee H, Grinspoon S.

    JAMA. 2008 Aug 6;300(5):509-19.PMID: 18677023 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Growth hormone versus placebo treatment for one year in growth hormone deficient adults: increase in exercise capacity and normalization of body composition.

    Jørgensen JO, Vahl N, Hansen TB, Thuesen L, Hagen C, Christiansen JS.

    Clin Endocrinol (Oxf). 1996 Dec;45(6):681-8.PMID: 9039333 [PubMed - indexed for MEDLINE]Related articles

    11.

    Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women.

    Khorram O, Laughlin GA, Yen SS.

    J Clin Endocrinol Metab. 1997 May;82(5):1472-9.PMID: 9141536 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Effects of physiologic growth hormone therapy on bone density and body composition in patients with adult-onset growth hormone deficiency. A randomized, placebo-controlled trial.

    Baum HB, Biller BM, Finkelstein JS, Cannistraro KB, Oppenhein DS, Schoenfeld DA, Michel TH, Wittink H, Klibanski A.

    Ann Intern Med. 1996 Dec 1;125(11):883-90.PMID: 8967668 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    The Australian Multicenter Trial of Growth Hormone (GH) Treatment in GH-Deficient Adults.

    Cuneo RC, Judd S, Wallace JD, Perry-Keene D, Burger H, Lim-Tio S, Strauss B, Stockigt J, Topliss D, Alford F, Hew L, Bode H, Conway A, Handelsman D, Dunn S, Boyages S, Cheung NW, Hurley D.

    J Clin Endocrinol Metab. 1998 Jan;83(1):107-16.PMID: 9435425 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Growth hormone replacement in healthy older men improves body composition but not functional ability.

    Papadakis MA, Grady D, Black D, Tierney MJ, Gooding GA, Schambelan M, Grunfeld C.

    Ann Intern Med. 1996 Apr 15;124(8):708-16.PMID: 8633830 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Oral testosterone supplementation increases muscle and decreases fat mass in healthy elderly males with low-normal gonadal status.

    Wittert GA, Chapman IM, Haren MT, Mackintosh S, Coates P, Morley JE.

    J Gerontol A Biol Sci Med Sci. 2003 Jul;58(7):618-25.PMID: 12865477 [PubMed - indexed for MEDLINE]Related articles

    16.

    Short-term growth hormone treatment in girls with Turner syndrome decreases fat mass and insulin sensitivity: a randomized, double-blind, placebo-controlled, crossover study.

    Gravholt CH, Naeraa RW, Brixen K, Kastrup KW, Mosekilde L, Jørgensen JO, Christiansen JS.

    Pediatrics. 2002 Nov;110(5):889-96.PMID: 12415026 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Recombinant growth hormone (GH) therapy in GH-deficient adults: a long-term controlled study on daily versus thrice weekly injections.

    Amato G, Mazziotti G, Di Somma C, Lalli E, De Felice G, Conte M, Rotondi M, Pietrosante M, Lombardi G, Bellastella A, Carella C, Colao A.

    J Clin Endocrinol Metab. 2000 Oct;85(10):3720-5.PMID: 11061530 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Growth hormone, insulin-like growth factors and their binding proteins in adult hemodialysis patients treated with recombinant human growth hormone.

    Jensen PB, Hansen TB, Frystyk J, Ladefoged SD, Pedersen FB, Christiansen JS.

    Clin Nephrol. 1999 Aug;52(2):103-9.PMID: 10480221 [PubMed - indexed for MEDLINE]Related articles

    19.

    Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: a randomized controlled trial.

    Emmelot-Vonk MH, Verhaar HJ, Nakhai Pour HR, Aleman A, Lock TM, Bosch JL, Grobbee DE, van der Schouw YT.

    JAMA. 2008 Jan 2;299(1):39-52. Erratum in: JAMA. 2008 Feb 13;299(6):634. PMID: 18167405 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Effect of alendronate and MK-677 (a growth hormone secretagogue), individually and in combination, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic women.

    Murphy MG, Weiss S, McClung M, Schnitzer T, Cerchio K, Connor J, Krupa D, Gertz BJ; MK-677/Alendronate Study Group.

    J Clin Endocrinol Metab. 2001 Mar;86(3):1116-25.PMID: 11238495 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data